Minerva Neurosciences (NERV) Total Non-Current Liabilities (2013 - 2026)

Minerva Neurosciences (NERV) has 11 years of Total Non-Current Liabilities data on file, last reported at $283.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 14437.98% year-over-year to $283.1 million; the trailing twelve-month figure through Mar 2026 stood at $283.1 million (up 14437.98% YoY), and the FY2025 full-year result was $173.8 million, up 176.52% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $283.1 million, up from $173.8 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $283.1 million in Q1 2026 and bottomed at $1.4 million in Q4 2022.
• The 5-year median for Total Non-Current Liabilities is $3.2 million (2022), against an average of $32.9 million.
• The widest annual swing landed in 2022, when Total Non-Current Liabilities slumped 55.04%; it then jumped 14437.98% in 2026.
• A 5-year view of Total Non-Current Liabilities shows it stood at $1.4 million in 2022, then jumped by 142.49% to $3.3 million in 2023, then surged by 1781.11% to $62.8 million in 2024, then surged by 176.52% to $173.8 million in 2025, then jumped by 62.92% to $283.1 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $283.1 million (Q1 2026), $173.8 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.

Peer Comparison